Systems medicine
- Associate Vice-President (Chinese Medicine Development) of HKBU;
- Tsang Shiu Tim Endowed Professor in Chinese Medicine Clinical Studies;
- Director and Chair Professor, Clinical Division;
- Director, Hong Kong Chinese Medicine Clinical Study Centre;
- Associate Director, Institute of Creativity;
- Director, Master of Science in Personal Health Management (Chinese Medicine) Programme
Biography 
Prof Bian Zhaoxiang had been educated in Nanjing University of Traditional Chinese Medicine (TCM), Beijing University of Traditional Chinese Medicine and Pharmacology and Guangzhou University of TCM, and was conferred the Ph.D. degree in Integrated Chinese and Western Medicine in 1994. After graduation, he engaged in clinical and basic research in digestive diseases in Guangzhou University of TCM. Under the Quality Migrant Admission Scheme of HKSAR, he moved to Hong Kong Baptist University in 2001. Prof Bian's research focuses mainly on the relationship between psychological stress and digestive diseases, especially focusing on the development and recurrence of irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colorectal cancer. Major research topics involve: i) Basic mechanism of visceral hyperalgesia and gastrointestinal motility disorder and its associated depression; 2) Psychological stress and colorectal cancer; 3) Clinical trial with Chinese medicine for digestive diseases, including IBS, IBD, functional constipation and colorectal cancer ; 4). New drug development based on Chinese herbal medicine and its active fraction for digestive diseases. He has been awarded second prize of National Science and Technology Award of China in 1999. Currently, Prof Bian serves as Director of Clinical Division, School of Chinese Medicine, and Associate Vice-President (Chinese Medicine Development) of HKBU.
+ More InformationResearch Interests
- Basic mechanism of visceral hyperalgesia and gastrointestinal motility disorder and its associated depression
- Psychological stress and colorectal cancer
- Clinical trial with Chinese medicine for digestive diseases, including IBS, IBD, functional constipation and colorectal cancer
- New drug development based on Chinese herbal medicine and its active fraction for digestive diseases.
Selected Publications
Zhu GY, Wong BCK, Wong I, Bian ZX, Fong WF, Yang ZJ. Alkylphenols from the roots of Ardisia brevicaulis induce cell cycle arrest and apoptosis through endoplasmic reticulum stress pathway in human non-small-cell lung cancer cells, Chem Pharm Bull (Tokyo)., 2012, 60(8): 1029-36.
Bian ZX*. Novel insights about the mechanism of visceral hypersensitivity in maternally separated rats. Neurogastroent & Motil, 2012; 24(7): 593-6.
Liao W, Wei H, Wang X, Qiu Y, Gou X, Zhang X, Zhou M, Wu J, Wu T, Kou F, Zhang Y, Bian ZX, Xie G, Jia W. Metabonomic Variations Associated with AOM-induced Precancerous Colorectal Lesions and Resveratrol Treatment. J Proteome Res., 2012, 11 (6): 3436–3448.
Zhang XJ, Choi FFK, Yan Z, Leung FP, Tan S, Lin SH, Xu HX, Jia W, Sung JJY, Cai ZW, Bian ZX*. Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics. FEBS J., 2012, 279: 2322–2331.
Qin HY, Xiao HT, Leung FP, Wu JCY, Sung JJY, Xu HX, Tong XD, Bian ZX*. JCM-16021, a Chinese herbal formula, attenuated visceral hyperalgesia in TNBS-induced post-inflammatory irritable bowel syndrome rats through reducing colonic EC cell hyperplasia and serotonin availability. Evid.-based Complement Altern. Med., 2012; 239638. Epub 2012 Jun 10.